Literature DB >> 7527013

Intratracheal administration of endotoxin and cytokines: VIII. LPS induces E-selectin expression; anti-E-selectin and soluble E-selectin inhibit acute inflammation.

T R Ulich1, S C Howard, D G Remick, E S Yi, T Collins, K Guo, S Yin, J L Keene, J J Schmuke, C N Steininger.   

Abstract

E-selectin is an inducible endothelial adhesion molecule that binds neutrophils. E-selectin mRNA is not constitutively detectable in the lungs of rats. Intratracheal injection of LPS induces pulmonary E-selectin mRNA expression at 2-4 h. Intratracheal injection of LPS followed at 2 and 4 h by intravenous injection of mouse F(ab')2 or F(ab') anti-E-selectin monoclonal antibody inhibits the emigration of neutrophils into the bronchoalveolar space at 6 h by 50-70%. TNF and IL-6 bioactivity are not decreased in bronchoalveolar lavage fluid after treatment with anti-E-selectin antibody as compared to controls, suggesting that the anti-E-selectin does not affect the magnitude of the LPS-initiated cytokine cascade. Intratracheal injection of LPS followed at 2 and 4 h by intravenous injection of soluble E-selectin inhibits neutrophilic emigration at 6 h by 64%, suggesting that endogenous soluble E-selectin shed from activated endothelium may play a role in the endogenous down-regulation of acute inflammation. E-selectin-mediated adhesion of neutrophils to endothelium appears crucial to the full development of the acute inflammation response.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7527013     DOI: 10.1007/bf01534436

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  21 in total

1.  Identification of an inducible endothelial-leukocyte adhesion molecule.

Authors:  M P Bevilacqua; J S Pober; D L Mendrick; R S Cotran; M A Gimbrone
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.

Authors:  M P Bevilacqua; S Stengelin; M A Gimbrone; B Seed
Journal:  Science       Date:  1989-03-03       Impact factor: 47.728

3.  A simple, non-chromatographic purification procedure for monoclonal antibodies. Isolation of monoclonal antibodies against cytochrome P450 isozymes.

Authors:  L M Reik; S L Maines; D E Ryan; W Levin; S Bandiera; P E Thomas
Journal:  J Immunol Methods       Date:  1987-06-26       Impact factor: 2.303

4.  Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone.

Authors:  A Waage
Journal:  Clin Immunol Immunopathol       Date:  1987-12

5.  Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes.

Authors:  P C Lord; L M Wilmoth; S B Mizel; C E McCall
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

6.  Tumor necrosis factor and interferon-gamma induce distinct patterns of endothelial activation and associated leukocyte accumulation in skin of Papio anubis.

Authors:  J M Munro; J S Pober; R S Cotran
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

7.  Role of endothelial-leukocyte adhesion molecule 1 (ELAM-1) in neutrophil-mediated lung injury in rats.

Authors:  M S Mulligan; J Varani; M K Dame; C L Lane; C W Smith; D C Anderson; P A Ward
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

8.  Expression of sialyl-Lewis X, an E-selectin ligand, in inflammation, immune processes, and lymphoid tissues.

Authors:  J M Munro; S K Lo; C Corless; M J Robertson; N C Lee; R L Barnhill; D S Weinberg; M P Bevilacqua
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

9.  Quantitation of leukocytes in bronchoalveolar lavage samples from rats after intravascular injection of endotoxin.

Authors:  J C Chang; M Lesser
Journal:  Am Rev Respir Dis       Date:  1984-01

10.  The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute inflammation.

Authors:  T R Ulich; S M Yin; K Z Guo; J del Castillo; S P Eisenberg; R C Thompson
Journal:  Am J Pathol       Date:  1991-03       Impact factor: 4.307

View more
  7 in total

1.  Endothelial cell function in patients with hereditary angioedema: elevated soluble E-selectin level during inter-attack periods.

Authors:  Judit Czúcz; Gyula Schaffer; Dorottya Csuka; Szilvia Walentin; Jan Kunde; Zoltán Prohászka; Henriette Farkas; László Cervenak
Journal:  J Clin Immunol       Date:  2011-10-19       Impact factor: 8.317

2.  Hypoxia aggravates lipopolysaccharide-induced lung injury.

Authors:  D Vuichard; M T Ganter; R C Schimmer; D Suter; C Booy; L Reyes; T Pasch; B Beck-Schimmer
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  The intratracheal administration of endotoxin: X. Dexamethasone downregulates neutrophil emigration and cytokine expression in vivo.

Authors:  E S Yi; D G Remick; Y Lim; W Tang; C E Nadzienko; A Bedoya; S Yin; T R Ulich
Journal:  Inflammation       Date:  1996-04       Impact factor: 4.092

4.  Protective effect of anti-P-selectin monoclonal antibody in lipopolysaccharide-induced lung hemorrhage.

Authors:  M Ohnishi; N Imanishi; S J Tojo
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

5.  Alveolar macrophages are required for protective pulmonary defenses in murine Klebsiella pneumonia: elimination of alveolar macrophages increases neutrophil recruitment but decreases bacterial clearance and survival.

Authors:  E Broug-Holub; G B Toews; J F van Iwaarden; R M Strieter; S L Kunkel; R Paine; T J Standiford
Journal:  Infect Immun       Date:  1997-04       Impact factor: 3.441

6.  Selectins and neutrophil traffic: margination and Streptococcus pneumoniae-induced emigration in murine lungs.

Authors:  J P Mizgerd; B B Meek; G J Kutkoski; D C Bullard; A L Beaudet; C M Doerschuk
Journal:  J Exp Med       Date:  1996-08-01       Impact factor: 14.307

Review 7.  Targeting vascular inflammation through emerging methods and drug carriers.

Authors:  Jia Nong; Patrick M Glassman; Vladimir R Muzykantov
Journal:  Adv Drug Deliv Rev       Date:  2022-03-07       Impact factor: 17.873

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.